QIAGEN Announces Exercise In Full of Over-Allotment Option by Underwriters in Offering of New Common Shares

(PresseBox) ( Venlo,the Netherlands, )
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Stock Exchange, regulated market (Prime Standard): QIA) (the "Company") announces that the underwriters for its offering of 27.5 million newly issued common shares (the "Offering") have exercised in full their over-allotment option to purchase 4,125,000 common shares (the "Additional Shares" and, together with the 27.5 million common shares, the "Shares"), and the Company will issue the Additional Shares at the price for the Offering, as previously announced, of US$ 20.25 per share (EUR 13.82).

The exercise of the over-allotment option brings the total number of common shares to be sold by QIAGEN in the Offering to 31,625,000. Gross proceeds of the Offering (including the Additional Shares) are expected to be approximately US$ 640 million (EUR 437 million).

The Company plans to use the net proceeds of the Offering to fund the acquisition of DxS Ltd. announced on September 22, 2009 and potential future acquisitions, to strengthen its balance sheet and for general corporate purposes.

Deutsche Bank, Goldman Sachs International and J.P. Morgan acted as Joint Global Coordinators and Joint Bookrunners of the Offering.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.